Skip to main content
HIKMA Pharmaceuticals PLC logo

HIKMA Pharmaceuticals PLC — Investor Relations & Filings

Ticker · HIK ISIN · GB00B0LCW083 LEI · 549300BNS685UXH4JI75 IL Manufacturing
Open in API
Filings indexed 829 across all filing types
Latest filing 2024-07-29 Board/Management Inform…
Country GB United Kingdom
Listing IL HIK

About HIKMA Pharmaceuticals PLC

https://www.hikma.com/home/

Hikma Pharmaceuticals is a global pharmaceutical company that develops, manufactures, and markets a broad portfolio of pharmaceutical products. The company's offerings include a wide range of generic, branded, specialty, and in-licensed medicines. It is a significant supplier of generic injectable products to hospitals and also provides oral generics and other specialty medications. With a focus on producing high-quality medicines, Hikma aims to make its products accessible to patients and healthcare providers across its key markets in North America, Europe, and the Middle East & North Africa (MENA) region.

Recent filings

Filing Released Lang Actions
Director Declaration
Board/Management Information Classification · 98% confidence The document explicitly states 'Director Declaration' and announces the appointment of a Senior Independent Non-Executive Director (Victoria Hull) to another company (IMI plc) effective on a future date, citing Listing Rule 9.6.14. This type of announcement, detailing changes in board membership or executive roles, directly corresponds to the definition of Board/Management Information (MANG). The RNS Number and the RNS distribution footer confirm it is a regulatory announcement, but the specific content points to MANG over the general RNS code.
2024-07-29 English
Notice of Results
Report Publication Announcement Classification · 99% confidence The document is a short announcement (3669 characters) released via RNS (London Stock Exchange news service). The core content states that Hikma Pharmaceuticals PLC "will announce its interim financial results for the six months ended 30 June 2024 on Thursday 8 August 2024." It also provides details for the subsequent Q&A conference call. Since this document is not the actual financial report (Interim Report/IR) but rather an announcement about *when* the report will be published and when the associated call will occur, it fits the definition of a Report Publication Announcement (RPA). It is not a general regulatory filing (RNS) because RPA is more specific for this context.
2024-07-15 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal notification filed with the RNS (Regulatory News Service) of the London Stock Exchange, identified by the 'RNS Number : 6522U' header and the concluding boilerplate text referencing RNS. The content explicitly states the 'Total Voting Rights and Capital' as of a specific date (30 June 2024) and provides the total number of shares with voting rights, referencing the FCA Disclosure Guidance and Transparency Rules. This type of mandatory disclosure regarding the total number of shares and voting rights is a standard regulatory announcement. While it relates to capital structure, it is not a financing activity (CAP) or a share issue/repurchase (SHA/POS), but rather a periodic update required by listing rules. Since it is a general regulatory announcement that doesn't fit the highly specific categories like DIRS, DIV, or MRQ, and it is a direct regulatory filing notification, the most appropriate general regulatory category is RNS, although it is very close to a 'Declaration of Voting Results & Voting Rights Announcement' (DVA) or a 'Share Issue/Capital Change' (SHA). However, given the context of a routine 'Total Voting Rights' update mandated by the FCA rules, RNS serves as the best fit for a general regulatory filing that isn't a specific report or transaction notice. The document length is short (3214 chars) and it is a direct announcement, not an announcement *of* a report.
2024-07-01 English
Director Declaration
Board/Management Information Classification · 98% confidence The document is a short announcement (1556 chars) filed via RNS (RNS Number : 2000U) from Hikma Pharmaceuticals Plc. The content explicitly announces a change regarding a director: 'Victoria Hull, Senior Independent Non-Executive Director, has been appointed as a Non-Executive Director of Serco Group PLC'. This directly relates to changes in the company's board or senior management structure. This aligns perfectly with the definition for Board/Management Information (MANG). It is not a Director's Dealing (DIRS) as it concerns an external appointment, not personal share transactions.
2024-06-27 English
Hikma acquires Xellia’s assets
M&A Activity Classification · 99% confidence The document is a formal announcement released via RNS (RNS Number : 6605S) on June 17, 2024, detailing Hikma Pharmaceuticals' agreement to acquire parts of Xellia's US finished dosage form (FDF) business and assets. This announcement describes a significant corporate transaction (Merger/Acquisition activity) involving cash consideration, asset transfer (manufacturing facility, R&D center), and strategic rationale. This clearly aligns with the definition of M&A Activity (TAR). Although it is distributed via RNS, the core content is the transaction itself, not just a general regulatory update or a report publication announcement.
2024-06-17 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is identified by the 'RNS Number' header and explicitly mentions 'RNS, the news service of the London Stock Exchange'. The content details a transaction involving a person discharging managerial responsibilities (Executive Chairman Said Darwazah) regarding the granting of a pledge over ordinary shares. This type of insider transaction disclosure is specifically covered by the 'Director's Dealing' definition. Although it is distributed via RNS, the specific nature of the filing points directly to DIRS (Director's Dealing) rather than the general RNS fallback category.
2024-06-05 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.